roginolisib
iOnctura Secures €80 Million in Series B Financing to Advance Rare Eye Cancer Treatment
iOnctura, Series B financing, rare eye cancer, uveal melanoma, roginolisib, cancer treatment
Actionable Insights Powered by AI
iOnctura, Series B financing, rare eye cancer, uveal melanoma, roginolisib, cancer treatment